Mutagenesis to Orient conjugation and preserve self‐adjuvant properties of flagellin in conjugates

Archive ouverte

Laneque, Laura | Lambert, Annie | Cayet, Delphine | Gilleron, Caroline | Courtois, Emmanuelle | Cloteau, Chloé | Broussard, Cédric | Annic, Bastien | Bessonnet, Thomas | Camberlein, Emilie | Sirard, Jean-Claude | Grandjean, Cyrille

Edité par CCSD ; Wiley-VCH Verlag -

International audience. Bacterial flagellins are unique for their capacity to activate both the innate and the adaptive immune response through a Toll‐like receptor 5 (TLR5) signaling cascade. Used as a carrier protein in conjugate vaccines it is crucial to preserve their self‐adjuvant properties during the conjugation step. Considering the absence of cysteine in the Salmonella enterica flagellin FliC sequence, we have investigated the impact of five mutations (A2C, K180C, T240C, D251C and S306C) alone or in combination on TLR5 activation. The FliC mutated at the four positions K180C, T240C, D251C and S306C displayed much the same activity as native flagellin whether the cysteine residues were free or conjugated. These results pave the way for the preparation of self‐adjuvanting conjugate vaccines based on cysteine‐mutated FliC as a carrier protein.

Suggestions

Du même auteur

Combination of molecular approaches to access homogeneous glycoconjugates for structure-immunogenicity relationship studies

Archive ouverte | Laneque, Laura | CCSD

International audience. Glycoconjugate vaccines consist of the conjugation of bacterial surface polysaccharides (PS) to a carrier protein. The latter allows the induction of antibodies directed against the carbohydr...

Glycoconjugate synthesis based on non-canonical amino acid incorporation for vaccine purpose

Archive ouverte | Laneque, Laura | CCSD

International audience

On the use of adenovirus dodecahedron as a carrier for glycoconjugate vaccines

Archive ouverte | Prasanna, Maruthi | CCSD

International audience. Virus-Like Particles (VLPs) have been used as immunogenic molecules in numerous recombinant vaccines. VLPs can also serve as vaccine platform to exogenous antigens, usually peptides incorpora...

Chargement des enrichissements...